SMART MESOPOROUS BALL
LIVE

Serial Number

98882779

Owner

CEN CO., LTD.

Attorney

Jihun Kim

Filing Date

Dec 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SMART MESOPOROUS BALL Trademark

Serial Number: 98882779

SMART MESOPOROUS BALL is a trademark filed by CEN CO., LTD. on December 3, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

CEN CO., LTD. (2 trademarks)

105, 761, Muan-ro, Bubuk-myeon
Miryang-si 50404 , KR

Entity Type: 03

Trademark Details

Filing Date

December 3, 2024

Registration Date

Not Registered

Published for Opposition

November 25, 2025

Goods & Services

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of a wide range of medical conditions, namely, for treating allergies, wounds, hypertension, pain, minor inflammation, diarrhea, influenza, insomnia, dermatitis, cold, headache, cough, heartburn and indigestion; vitamin and mineral food supplements; crude medicines, namely, medicines for the treatment and prevention of atopic skin disease, obesity, digestive disorders, and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, and for skin care; radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical preparations for the treatment of cancer and infectious diseases; pharmaceutical drugs for the treatment of oncological, viral, bacterial and autoimmunity diseases; medicated pastilles for pharmaceutical purposes for the treatment of cardio-vascular irregularities, gastrointestinal disorder, allergies, diarrhea, obesity, influenza, immune system disorder, immune system imbalance, anxiety disorder, stress disorder, attention-deficit hyperactivity disorder, dyslexia, sleep disorder, insomnia, chronic fatigue syndrome, irritable bowel syndrome, oral flora disorder, chronic pain, chronic inflammation, depression, headaches, osteoporosis, neuralgic pain, nervous system dysfunction, nutrient deficiency, muscle pain, neurodermatitis, dermatitis, skin injury, mucosal disease, kidney disease, liver disease, biliary disease, gastric acid disorder, hormone disorder, joint pain, post-Covid syndrome, concentration and memory disorder, cough, ear disease, nose disease, throat disease, and sore throat; medicated lotions for pharmaceutical purposes, namely, burn relief lotions, lotions for wound treatment, and lotions for allergy treatment; chemical preparations for pharmaceutical use, namely, for the treatment of neurodegenerative disorders, neurological conditions, cancer, skin conditions, fungal, viral, bacterial and infectious diseases, and for use in wound healing or photodynamic therapy

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 20, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2025 CNRT
ASSIGNED TO EXAMINER
May 22, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2024 NWOS
NEW APPLICATION ENTERED
Dec 3, 2024 NWAP